Enzyme immunoassay for the quantitative determination of antibodies to Trastuzumab (Herceptin®, Herclon®) in serum and plasma with confirmation.
This kit has been especially developed for the quantitative antibodies to Trastuzumab in serum and plasma samples
Trastuzumab (Herceptin®, Herclon®)was associated to the development of anti-trastuzumab antibodies, even some were reported to be neutralizing, in various percentages of patients during therapy with the drug (Herceptin®, Herclon®). This might lead to severe complications. This kit can be efficiently used for monitoring anti- trastuzumab antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti-trastuzumab antibodies.
All SHIKARI® ELISA kits are suitable for biosimilar work.
